34 reports

Cardiovascular devices segment includes products such as CRM devices, interventional cardiology device, peripheral vascular device, cardiovascular surgery device, prosthetic heart valve device, electrophysiology device,

  • Eye Disease
  • World
  • Market Size
  • Masimo Corporation
  • Medtronic, Inc.

Figure ##: Global Ophthalmic Devices Market, Historic Market Size, 2013-2017, $ Billion P A G E | ## Table ##: Global Ophthalmic Devices Market, Historic Market Size, 2013-2017, $ Billion The global Ophthalmic Devices market grew from $##. ## billion in 2013 t

  • Eye Disease
  • World
  • Alcon, Inc.
  • Carl Zeiss Meditec AG
  • Essilor group

You can easily book an appointment with one online.

  • Eye Disease
  • World
  • Alcon, Inc.
  • Allergan plc
  • Otsuka Pharmaceutical Co., Ltd.

It offers metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and POC diagnostic devices.

  • Eye Disease
  • Pharmaceutical
  • United States
  • Company Financials
  • Novartis AG

Drivers and Their Impact Impact on Key Customer Category High Incidence of Eye Diseases Increased Prevalence of Chronic Diseases High Unmet Medical Needs ## ## ## ## ## Hospitals Low Low ## ## ## ## ## High High Low Low ## ## ## ## ## High High Improved Diagnosis Promising Drug Pipeline

  • Eye Disease
  • Actavis plc
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Novartis AG

NovelMed also provides Inflammin, a cardiovascular device that converts the blood into a form that resists AP activation during cardiac procedures.

  • Eye Disease
  • Therapy
  • United States
  • Product Initiative
  • Formycon AG
  • NOVARTIS AG
  • PIPELINE BY NOVARTIS AG, H2 2018

NovelMed also provides Inflammin, a cardiovascular device that converts the blood into a form that resists AP activation during cardiac procedures.

  • Eye Disease
  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • Alexion Pharmaceuticals, Inc.
  • PIPELINE BY NOVARTIS AG, H1 2018

NovelMed also provides Inflammin, a cardiovascular device that converts the blood into a form that resists AP activation during cardiac procedures.

  • Eye Disease
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Alexion Pharmaceuticals, Inc.

DEAL IN BRIEF Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement Company type PARTNER ##: ALCON COMPANY INFORMATION: PARTNERS Alcon Bausch & Lomb Incorporated Announced Partnership Other Aug ##, 2007 Private Alcon (or ' the company' ), a

  • Eye Disease
  • Eyewear
  • United States
  • M&A
  • Bausch & Lomb Incorporated

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Clinical Trial
  • Eye Disease
  • Eyewear
  • Ophthalmology
  • Bausch & Lomb Incorporated

WE TRACK MEDICAL DEVICES THAT ARE IN DEVELOPMENT RELATED TO NEARLY ## MARKETS (I. E., CARDIOVASCULAR DEVICES, DENTAL DEVICES ETC) THAT WE COVER.

  • Drug Development
  • Eye Disease
  • Eyewear
  • United States
  • Company

We track medical devices that are in development related to nearly ## markets (i. e., cardiovascular devices, dental devices etc) that we cover.

  • Clinical Trial
  • Eye Disease
  • Ophthalmology
  • Refractive Surgery Device
  • Novartis AG

One unit refers to one glaucoma drainage device.

  • Eye Disease
  • Medical Textile
  • Ophthalmology
  • United States
  • Glaukos Corporation

NovelMed also provides Inflammin, a cardiovascular device that converts the blood into a form that resists AP activation during cardiac procedures.

  • Eye Disease
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • CHOROIDAL NEOVASCULARIZATION - PIPELINE BY LUPIN LTD, H1 2018

NovelMed also provides Inflammin, a cardiovascular device that converts the blood into a form that resists AP activation during cardiac procedures.

  • Eye Disease
  • Therapy
  • United States
  • World
  • Product Initiative

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Clinical Trial
  • Drug Development
  • Eye Disease
  • Eyewear
  • EyeKon Medical, Inc.

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Eye Disease
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Eye Disease
  • Health Services
  • Ophthalmology
  • United States
  • Ocular Therapeutix, Inc.

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Drug Development
  • Eye Disease
  • United States
  • Company
  • Molecular Partners AG

DEAL IN BRIEF Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement Company type PARTNER ##: ALCON COMPANY INFORMATION: PARTNERS Alcon Bausch & Lomb Incorporated Announced Partnership Other Aug ##, 2007 Private Alcon (or ' the company' ), a

  • Eye Disease
  • Eyewear
  • United States
  • M&A
  • Bausch & Lomb Incorporated

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Clinical Trial
  • CT Scan
  • Eye Disease
  • Ophthalmology
  • Carl Zeiss Meditec AG

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Eye Disease
  • Ophthalmology
  • United States
  • Company Financials
  • Glaukos Corporation

WE TRACK MEDICAL DEVICES THAT ARE IN DEVELOPMENT RELATED TO NEARLY ## MARKETS (IE, CARDIOVASCULAR DEVICES, DENTAL DEVICES ETC) THAT WE COVER.

  • Eye Disease
  • Medical Device
  • Prosthesis
  • United States
  • Product Initiative

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Eye Disease
  • Eyewear
  • Ophthalmology
  • United States
  • Bausch & Lomb Incorporated

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Eye Disease
  • Ophthalmology
  • Germany
  • Company
  • Heidelberg Engineering GmbH

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Eye Disease
  • Medical Device
  • United States
  • Company
  • Valeant Pharmaceuticals International, Inc.

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Clinical Trial
  • Eye Disease
  • Eyewear
  • Ophthalmology
  • Valeant Pharmaceuticals International, Inc.
  • GEORG-AUGUST-UNIVERSITAT GOTTINGEN PIPELINE PRODUCTS SUMMARY BY DEVELOPMENT STAGE

It is designed to detect C##a-receptors or complement component ##a receptor ## (C##AR##) specific to inflammatory diseases in patient' s samples using monoclonal antibodies.

  • Biomarker
  • Dementia
  • Eye Disease
  • Genomics Proteomics And Enabling Technology
  • Mirna Therapeutics, Inc.

We track medical devices that are in development related to nearly ## markets (ie, cardiovascular devices, dental devices etc) that we cover.

  • Eye Disease
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

WE TRACK MEDICAL DEVICES THAT ARE IN DEVELOPMENT RELATED TO NEARLY ## MARKETS (IE, CARDIOVASCULAR DEVICES, DENTAL DEVICES ETC) THAT WE COVER.

  • Eye Disease
  • Laboratory
  • Ophthalmology
  • United States
  • Alcon, Inc.